Affiliation:
1. Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
2. Department of Bioengineering, University of Washington, Seattle, Washington, USA
Abstract
ABSTRACT
Staphylococcus aureus
is an important human pathogen, but studies of the organism have suffered from the lack of a robust tool set for its genetic and genomic manipulation. Here we report the development of a system for the facile and high-throughput genomic engineering of
S. aureus
using single-stranded DNA (ssDNA) oligonucleotide recombineering coupled with clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-mediated counterselection. We identify recombinase
EF2132
, derived from
Enterococcus faecalis
, as being capable of integrating single-stranded DNA oligonucleotides into the
S. aureus
genome. We found that
EF2132
can readily mediate recombineering across multiple characterized strains (3 of 3 tested) and primary clinical isolates (6 of 6 tested), typically yielding thousands of recombinants per transformation. Surprisingly, we also found that some
S. aureus
strains are naturally recombinogenic at measurable frequencies when oligonucleotides are introduced by electroporation, even without exogenous recombinase expression. We construct a temperature-sensitive, two-vector system which enables conditional recombineering and CRISPR/Cas9-mediated counterselection in
S. aureus
without permanently introducing exogenous genetic material or unintended genetic lesions. We demonstrate the ability of this system to efficiently and precisely engineer point mutations and large single-gene deletions in the
S. aureus
genome and to yield highly enriched populations of engineered recombinants even in the absence of an externally selectable phenotype. By virtue of utilizing inexpensive, commercially synthesized synthetic DNA oligonucleotides as substrates for recombineering and counterselection, this system provides a scalable, versatile, precise, inexpensive, and generally useful tool for producing isogenic strains in
S. aureus
which will enable the high-throughput functional assessment of genome variation and gene function across multiple strain backgrounds.
IMPORTANCE
Engineering genetic changes in bacteria is critical to understanding the function of particular genes or mutations but is currently a laborious and technically challenging process to perform for the important human pathogen
Staphylococcus aureus
. In an effort to develop methods which are rapid, easy, scalable, versatile, and inexpensive, here we describe a system for incorporating synthetic, mutagenic DNA molecules into the
S. aureus
genome and for eliminating cells that lack the engineered mutation. This method allows efficient, precise, and high-throughput genetic engineering of
S. aureus
strains and will facilitate studies seeking to address a variety of issues about the function of particular genes and specific mutations.
Funder
Cystic Fibrosis Foundation
Publisher
American Society for Microbiology
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献